161 related articles for article (PubMed ID: 6432835)
1. Effects of manganese on the growth and morphology of Ureaplasma urealyticum.
Robertson JA; Chen MH
J Clin Microbiol; 1984 Jun; 19(6):857-64. PubMed ID: 6432835
[TBL] [Abstract][Full Text] [Related]
2. Colony morphology, ultrastructure and morphogenesis in Mycoplasma hominis, Acholeplasma laidlawii and Ureaplasma urealyticum.
Meloni GA; Bertoloni G; Busolo F; Conventi L
J Gen Microbiol; 1980 Feb; 116(2):435-43. PubMed ID: 7373281
[TBL] [Abstract][Full Text] [Related]
3. Effect of ammonium ion concentration and osmotic pressure on growth of Ureaplasma urealyticum (T-strain mycoplasma).
Sayed IA; Kenny GE
J Bacteriol; 1978 Jun; 134(3):967-72. PubMed ID: 26668
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.
Waites KB; Duffy LB; Schmid T; Crabb D; Pate MS; Cassell GH
Antimicrob Agents Chemother; 1991 Jun; 35(6):1181-5. PubMed ID: 1929260
[TBL] [Abstract][Full Text] [Related]
5. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.
Kenny GE; Cartwright FD
Antimicrob Agents Chemother; 1994 Nov; 38(11):2628-32. PubMed ID: 7872759
[TBL] [Abstract][Full Text] [Related]
6. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
Rylander M; Hallander HO
Scand J Infect Dis Suppl; 1988; 53():12-7. PubMed ID: 2843982
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural changes in mollicutes induced by the peptide antibiotic herbicolin A.
Birkelund S; Freundt EA; Christiansen G
Antimicrob Agents Chemother; 1986 Feb; 29(2):371-3. PubMed ID: 3717939
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
Renaudin H; Bébéar C
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):838-41. PubMed ID: 1964899
[TBL] [Abstract][Full Text] [Related]
9. Growth characteristics of ureaplasmas from animal and human sources.
Stemke GW; Stemler ME; Robertson JA
Isr J Med Sci; 1984 Oct; 20(10):935-7. PubMed ID: 6392176
[TBL] [Abstract][Full Text] [Related]
10. Comparison of glycoproteins from ten human Mycoplasma species.
Kobayashi K; Watanabe T
Microbios; 1991; 67(270):23-33. PubMed ID: 1815100
[TBL] [Abstract][Full Text] [Related]
11. Mollicutes DNA polymerases: characterization of a single enzyme from Mycoplasma mycoides and Ureaplasma urealyticum and of three enzymes from Acholeplasma laidlawii.
Maurel D; Charron A; Bébéar C
Res Microbiol; 1989; 140(3):191-205. PubMed ID: 2694245
[TBL] [Abstract][Full Text] [Related]
12.
Waites KB; Crabb DM; Xiao L; Duffy LB
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784668
[TBL] [Abstract][Full Text] [Related]
13. In vitro antimycoplasmal activity of mepartricin.
Meloni GA; Busolo F; Bortolon P; Ruozi P
Farmaco Sci; 1979 Mar; 34(3):183-8. PubMed ID: 118890
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of Ureaplasma urealyticum growth on a differential agar medium (A7B) by a polyamine, putrescine.
Shepard MC; Combs RS
J Clin Microbiol; 1979 Dec; 10(6):931-3. PubMed ID: 521491
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of fleroxacin (RO 23-6240) against Ureaplasma urealyticum and Mycoplasma hominis.
Krausse R; Ullmann U
Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):67-9. PubMed ID: 3132382
[TBL] [Abstract][Full Text] [Related]
16. Morphology of Ureaplasma urealyticum (T-mycoplasma) organisms and colonies.
Razin S; Masover GK; Palant M; Hayflick L
J Bacteriol; 1977 Apr; 130(1):464-71. PubMed ID: 15986
[TBL] [Abstract][Full Text] [Related]
17. [Comparative activity of minocycline and doxycycline on mycoplasmas pathogenic for man].
Bebear C; Cantet P; Renaudin H; Quentin C
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):577-80. PubMed ID: 3937130
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activities of investigational peptide deformylase inhibitor NVP LBM-415 and other agents against human mycoplasmas and ureaplasmas.
Waites KB; Reddy NB; Crabb DM; Duffy LB
Antimicrob Agents Chemother; 2005 Jun; 49(6):2541-2. PubMed ID: 15917568
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the vascular permeability-increasing activity of bradykinin by mycoplasmas.
Shibata K; Watanabe T
FEMS Microbiol Lett; 1989 Nov; 53(1-2):149-52. PubMed ID: 2515097
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of trospectomycin sulphate against Mycoplasma and Ureaplasma species isolated from humans.
Yancey RJ; Klein LK
J Antimicrob Chemother; 1988 Jun; 21(6):731-6. PubMed ID: 2970452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
